| 52 Week Rng | - |
| Market Cap | - |
| Avg Volume | - |
| 1M Volatility | - |
| Short Ratio | - |
| P/E Ratio (TTM) | - |
| P/E Ratio (Fwd) | - |
| P/B Ratio | - |
| Div & Yield | - |
MinorCrew • Aalto Investment Management Game (Fall 2020) • Dec 2020
Closing position
Group13 • Aalto Investment Management Game (Fall 2020) • Nov 2020
We sell it because it doesn’t fit our strategy.
MorrisMarketNeutral • Stockfuse Continuum (US) • Nov 2020
Closing position
Short_VIX • Aalto Investment Management Game (Fall 2020) • Nov 2020
Short position. Pharmaceutical companies are likely to be affected negatively due to US elections.
KTOCapital • Aalto Investment Management Game (Fall 2020) • Nov 2020
Passive Buy-Hold Strategy, Long Position. Undervalued in the medical sector based on P/E ratio compared to peers.
Erottaja • Aalto Investment Management Game (Fall 2020) • Nov 2020
Passive Healthcare index investing strategy. 30 largest companies by market cap (Excluding the ones not available in Stockfuse). Following Spliced Health Care Index. Weight of BIIB is 3.4%.
Täffä_Spagetti_Analytics • Aalto Investment Management Game (Fall 2020) • Nov 2020
Biogen Idec inc. Short position Constructing our initial portfolio The firm has recently reached its 52-week low so according to our 52-week high/low momentum investment strategy, we expect the firm to be decreasing in value further in the near future due to the negative momentum it is experiencing. (Aiming for 1.8 leverage ratio)
Arsenal • Aalto Investment Management Game (Fall 2020) • Nov 2020
Our investment strategy is passive investing. The portfolio follows Nasdaq 100 index, choosing stocks with highest EPS ratios and low price-to-book ratios compared to stocks with similar EPS ratio. This stock offers relatively high returns with low P/B ratio. The initial positions are equally weighted so $100k is allocated to this stock.